SEC Suspends Trading Of Company That Sold ‘At-Home’ COVID-19 Tests

(By Tom Dreisbach for NPR)

The U.S. Securities and Exchange Commission has temporarily suspended trading of shares of Wellness Matrix Group, citing statements “made through affiliated websites and a company consultant about selling at-home COVID-19 testing kits that had been approved by the FDA.”

The suspension lasts until April 22.

As NPR first reported last week, the California-based Wellness Matrix Group had been selling an “at-home” test kit for COVID-19, and, at times, claimed that test was “FDA Approved.”  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.